Clinical trial
Post-Operative Adjuvant Concurrent Chemoradiotherapy For High Risk Oral Cavity…
NCT00201383 · National Health Research Institutes, Taiwan, Other · Completed
Key facts
| NCT number | NCT00201383 |
|---|---|
| Title | Post-Operative Adjuvant Concurrent Chemoradiotherapy For High Risk Oral Cavity Squamous Cell Carcinoma Patients |
| Official title | Phase III Study Of Post-Operative Adjuvant Concurrent Chemoradiotherapy For High Risk Oral Cavity Squamous Cell Carcinoma Patients |
| Lead sponsor | National Health Research Institutes, Taiwan, Other |
| Collaborators | National Taiwan University Hospital Changhua Christian Hospital China Medical University Hospital Buddhist Tzu Chi General Hospital Mackay Memorial Hospital Koo Foundation Sun Yat-Sen Cancer Center… |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Oral Cavity, Squamous Cell Carcinoma |
| Intervention type | Drug |
| Interventions | cisplatin |
| Enrollment | 161 |
| Start date | Oct 1, 1999 |
| Completion | Aug 1, 2009 |
| First posted | Sep 20, 2005 |
| Last update posted | Sep 20, 2005 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: